The Clorox Company (NYSE:CLX) Shares Acquired by Quent Capital LLC

Quent Capital LLC increased its position in The Clorox Company (NYSE:CLXFree Report) by 22.3% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 807 shares of the company’s stock after acquiring an additional 147 shares during the period. Quent Capital LLC’s holdings in Clorox were worth $131,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Sovran Advisors LLC acquired a new position in shares of Clorox in the fourth quarter valued at approximately $261,000. Stonebridge Financial Group LLC acquired a new position in Clorox during the fourth quarter worth approximately $83,000. Essex Financial Services Inc. increased its position in Clorox by 24.3% during the fourth quarter. Essex Financial Services Inc. now owns 2,327 shares of the company’s stock worth $378,000 after purchasing an additional 455 shares during the last quarter. Regents Gate Capital LLP acquired a new position in Clorox during the fourth quarter worth approximately $269,000. Finally, Soltis Investment Advisors LLC acquired a new position in Clorox during the fourth quarter worth approximately $566,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

Shares of CLX stock opened at $148.66 on Thursday. The company has a market capitalization of $18.40 billion, a PE ratio of 40.62, a price-to-earnings-growth ratio of 2.52 and a beta of 0.42. The firm has a fifty day simple moving average of $160.30 and a 200-day simple moving average of $159.26. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the business posted $2.16 EPS. Equities research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.28%. Clorox’s dividend payout ratio (DPR) is 133.33%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on CLX shares. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. increased their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Evercore ISI increased their price objective on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $158.21.

Get Our Latest Report on CLX

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.